Effect of 2'-deoxycoformycin on the inhibition of deoxyribonucleic acid synthesis by 9-beta-D-arabinofuranosyladenine 5'-triphosphate.
D058892:Adenosine Deaminase Inhibitors; D000818:Animals; D001088:Arabinonucleotides / Q000494:pharmacology*; D002478:Cells, Cultured; D003070:Coformycin / Q000031:analogs & derivatives / Q000494:pharmacology*; D006224:Cricetinae; D003412:Cricetulus; D004247:DNA / Q000096:biosynthesis*; D003641:Deamination; D004347:Drug Interactions; D005260:Female; D009700:Nucleoside Deaminases / Q000037:antagonists & inhibitors*; D015649:Pentostatin; D010766:Phosphorylation; D012263:Ribonucleosides / Q000494:pharmacology*; D013936:Thymidine / Q000378:metabolism; D013997:Time Factors; D014740:Vidarabine / Q000378:metabolism; D001084:Vidarabine Phosphate / Q000031:analogs & derivatives / Q000494:pharmacology*
D058892:Adenosine Deaminase Inhibitors; D001088:Arabinonucleotides; D012263:Ribonucleosides; D001084:Vidarabine Phosphate; D003070:Coformycin; C000101:ara-ATP; D015649:Pentostatin; D004247:DNA; D009700:Nucleoside Deaminases; D014740:Vidarabine; D013936:Thymidine